Avity Investment Management Inc. Abbott Laboratories Transaction History

Avity Investment Management Inc.

$1.25 Billion
Q3 2024

A detailed history of Avity Investment Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Avity Investment Management Inc. holds 17,523 shares of ABT stock, worth $2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

17,523

Previous 38,824 54.87%

Holding current value

$2 Million

Previous $4.03 Million 50.5%

% of portfolio

0.16%

Previous 0.33%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $2.13 Million - $2.52 Million	-21,301 Reduced 54.87%	17,523 $2 Million
Q2 2024 Jul 11, 2024	SELL	$100.73 - $112.44 $6.85 Million - $7.65 Million	-68,002 Reduced 63.66%	38,824 $4.03 Million
Q1 2024 Apr 16, 2024	BUY	$109.52 - $120.96 $294,061 - $324,777	2,685 Added 2.58%	106,826 $12.1 Million
Q4 2023 Jan 11, 2024	SELL	$90.19 - $110.4 $14.9 Million - $18.3 Million	-165,630 Reduced 61.4%	104,141 $11.5 Million
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $2.62 Million - $3.14 Million	-27,420 Reduced 9.23%	269,771 $26.1 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $354,443 - $394,923	3,517 Added 1.2%	297,191 $32.4 Million
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $336,104 - $395,614	3,470 Added 1.2%	293,674 $29.7 Million
Q4 2022 Jan 12, 2023	BUY	$95.06 - $111.52 $2.27 Million - $2.67 Million	23,927 Added 8.99%	290,204 $31.9 Million
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $1.96 Million - $2.27 Million	20,283 Added 8.25%	266,277 $25.8 Million
Q2 2022 Jul 13, 2022	BUY	$102.07 - $123.37 $6.52 Million - $7.88 Million	63,910 Added 35.1%	245,994 $26.7 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $368,854 - $449,794	3,235 Added 1.81%	182,084 $21.6 Million
Q4 2021 Jan 14, 2022	SELL	$115.53 - $141.46 $96,467 - $118,119	-835 Reduced 0.46%	178,849 $25.2 Million
Q3 2021 Oct 13, 2021	SELL	$116.66 - $129.06 $424,059 - $469,133	-3,635 Reduced 1.98%	179,684 $21.2 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $17,878 - $21,045	-169 Reduced 0.09%	183,319 $21.3 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $1.26 Million - $1.49 Million	-11,622 Reduced 5.96%	183,488 $22 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $164,010 - $178,724	-1,562 Reduced 0.79%	195,110 $21.4 Million
Q3 2020 Oct 08, 2020	BUY	$91.64 - $111.29 $6,506 - $7,901	71 Added 0.04%	196,672 $21.4 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $1.38 Million - $1.76 Million	-17,973 Reduced 8.38%	196,601 $18 Million
Q1 2020 Apr 09, 2020	SELL	$62.82 - $91.86 $288,657 - $422,096	-4,595 Reduced 2.1%	214,574 $16.9 Million
Q4 2019 Jan 15, 2020	BUY	$78.51 - $87.4 $1.4 Million - $1.56 Million	17,829 Added 8.86%	219,169 $19 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $1.41 Million - $1.53 Million	17,286 Added 9.39%	201,340 $16.8 Million
Q2 2019 Jul 22, 2019	BUY	$72.88 - $85.0 $1.95 Million - $2.27 Million	26,740 Added 17.0%	184,054 $15.5 Million
Q1 2019 Apr 12, 2019	BUY	$66.22 - $80.06 $5.06 Million - $6.12 Million	76,425 Added 94.48%	157,314 $12.6 Million
Q4 2018 Jan 22, 2019	BUY	$65.56 - $74.27 $4.8 Million - $5.44 Million	73,215 Added 954.07%	80,889 $5.85 Million
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $194,531 - $234,678	-3,199 Reduced 29.42%	7,674 $563,000
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $126,711 - $139,851	-2,201 Reduced 16.83%	10,873 $663,000
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $19,694 - $22,267	-350 Reduced 2.61%	13,074 $783,000
Q4 2017 Jan 10, 2018	BUY	$53.68 - $57.47 $257,664 - $275,856	4,800 Added 55.66%	13,424 $766,000
Q3 2017 Oct 20, 2017	BUY	$48.06 - $53.64 $414,469 - $462,591	8,624	8,624 $460,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avity Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avity Investment Management Inc. with notifications on news.

Account

Avity Investment Management Inc. Abbott Laboratories Transaction History